In March 2025, the company introduced new designs for a immediate-to-buyer offering of its Wegovy weight loss drug. The company established a whole new pharmacy, termed NovoCare, which would cost prospects $499 per 30 days for usage of the drug, under fifty percent the expense of the drug by way